Annual Accounts Receivable
$3.49 M
-$2.05 M-37.02%
31 December 2023
Summary:
Utah Medical Products annual accounts receivable is currently $3.49 million, with the most recent change of -$2.05 million (-37.02%) on 31 December 2023. During the last 3 years, it has fallen by -$736.00 thousand (-17.42%). UTMD annual accounts receivable is now -37.02% below its all-time high of $5.54 million, reached on 31 December 2022.UTMD Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$3.72 M
+$52.00 K+1.42%
30 September 2024
Summary:
Utah Medical Products quarterly accounts receivable is currently $3.72 million, with the most recent change of +$52.00 thousand (+1.42%) on 30 September 2024. Over the past year, it has increased by +$233.00 thousand (+6.68%). UTMD quarterly accounts receivable is now -38.66% below its all-time high of $6.07 million, reached on 31 March 2012.UTMD Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTMD Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.0% | +6.7% |
| 3 y3 years | -17.4% | -23.4% |
| 5 y5 years | -14.2% | -26.6% |
UTMD Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -37.0% | at low | -38.4% | +6.7% |
| 5 y | 5 years | -37.0% | at low | -38.4% | +6.7% |
| alltime | all time | -37.0% | +12.8% | -38.7% | +20.3% |
Utah Medical Products Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.72 M(+1.4%) |
| June 2024 | - | $3.67 M(+2.1%) |
| Mar 2024 | - | $3.59 M(+3.0%) |
| Dec 2023 | $3.49 M(-37.0%) | $3.49 M(+0.0%) |
| Sept 2023 | - | $3.49 M(-3.2%) |
| June 2023 | - | $3.60 M(-5.6%) |
| Mar 2023 | - | $3.82 M(-31.1%) |
| Dec 2022 | $5.54 M(+4.7%) | $5.54 M(-8.2%) |
| Sept 2022 | - | $6.03 M(+22.2%) |
| June 2022 | - | $4.94 M(-13.7%) |
| Mar 2022 | - | $5.72 M(+8.2%) |
| Dec 2021 | $5.29 M(+25.2%) | $5.29 M(+8.9%) |
| Sept 2021 | - | $4.85 M(+5.4%) |
| June 2021 | - | $4.61 M(+10.8%) |
| Mar 2021 | - | $4.16 M(-1.6%) |
| Dec 2020 | $4.22 M(-12.6%) | $4.22 M(-1.2%) |
| Sept 2020 | - | $4.28 M(+12.8%) |
| June 2020 | - | $3.79 M(-14.0%) |
| Mar 2020 | - | $4.41 M(-8.8%) |
| Dec 2019 | $4.83 M(+19.0%) | $4.83 M(-4.6%) |
| Sept 2019 | - | $5.07 M(-3.2%) |
| June 2019 | - | $5.24 M(+6.6%) |
| Mar 2019 | - | $4.91 M(+20.8%) |
| Dec 2018 | $4.06 M(+9.5%) | $4.06 M(-9.2%) |
| Sept 2018 | - | $4.48 M(-1.2%) |
| June 2018 | - | $4.53 M(+7.7%) |
| Mar 2018 | - | $4.21 M(+13.4%) |
| Dec 2017 | $3.71 M(+12.9%) | $3.71 M(-21.5%) |
| Sept 2017 | - | $4.73 M(+5.7%) |
| June 2017 | - | $4.47 M(+7.1%) |
| Mar 2017 | - | $4.18 M(+27.0%) |
| Dec 2016 | $3.29 M(-12.3%) | $3.29 M(-34.6%) |
| Sept 2016 | - | $5.03 M(+1.1%) |
| June 2016 | - | $4.98 M(-7.9%) |
| Mar 2016 | - | $5.40 M(+44.1%) |
| Dec 2015 | $3.75 M(-6.1%) | $3.75 M(-31.7%) |
| Sept 2015 | - | $5.49 M(-2.1%) |
| June 2015 | - | $5.61 M(+12.0%) |
| Mar 2015 | - | $5.01 M(+25.5%) |
| Dec 2014 | $3.99 M(+6.4%) | $3.99 M(-14.1%) |
| Sept 2014 | - | $4.65 M(-14.7%) |
| June 2014 | - | $5.45 M(+7.3%) |
| Mar 2014 | - | $5.08 M(+35.2%) |
| Dec 2013 | $3.75 M | $3.75 M(-24.4%) |
| Sept 2013 | - | $4.96 M(-12.5%) |
| June 2013 | - | $5.67 M(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $5.36 M(+34.4%) |
| Dec 2012 | $3.99 M(-12.9%) | $3.99 M(-20.8%) |
| Sept 2012 | - | $5.04 M(-1.0%) |
| June 2012 | - | $5.09 M(-16.1%) |
| Mar 2012 | - | $6.07 M(+32.3%) |
| Dec 2011 | $4.58 M(+44.9%) | $4.58 M(-8.8%) |
| Sept 2011 | - | $5.03 M(+1.2%) |
| June 2011 | - | $4.96 M(+56.9%) |
| Dec 2010 | $3.16 M(+0.2%) | $3.16 M(+0.2%) |
| Dec 2009 | $3.16 M(-7.2%) | $3.16 M(-7.2%) |
| Dec 2008 | $3.40 M(-9.4%) | $3.40 M(-7.9%) |
| Sept 2008 | - | $3.69 M(-7.6%) |
| June 2008 | - | $4.00 M(-1.8%) |
| Mar 2008 | - | $4.07 M(+8.5%) |
| Dec 2007 | $3.75 M(+7.1%) | $3.75 M(-5.9%) |
| Sept 2007 | - | $3.99 M(-3.2%) |
| June 2007 | - | $4.12 M(-3.6%) |
| Mar 2007 | - | $4.28 M(+22.0%) |
| Dec 2006 | $3.51 M(+1.1%) | $3.51 M(-8.1%) |
| Sept 2006 | - | $3.81 M(-1.6%) |
| June 2006 | - | $3.88 M(-19.6%) |
| Mar 2006 | - | $4.83 M(+39.1%) |
| Dec 2005 | $3.47 M(-7.0%) | $3.47 M(+0.1%) |
| Sept 2005 | - | $3.47 M(-11.9%) |
| June 2005 | - | $3.94 M(+0.5%) |
| Mar 2005 | - | $3.92 M(+5.0%) |
| Dec 2004 | $3.73 M(+12.1%) | $3.73 M(+16.2%) |
| Sept 2004 | - | $3.21 M(-8.3%) |
| June 2004 | - | $3.50 M(+1.5%) |
| Mar 2004 | - | $3.45 M(+3.7%) |
| Dec 2003 | $3.33 M(+7.5%) | $3.33 M(-10.2%) |
| Sept 2003 | - | $3.71 M(+9.4%) |
| June 2003 | - | $3.39 M(+1.1%) |
| Mar 2003 | - | $3.35 M(+8.3%) |
| Dec 2002 | $3.09 M(-13.7%) | $3.09 M(-8.8%) |
| Sept 2002 | - | $3.39 M(-2.0%) |
| June 2002 | - | $3.46 M(-6.2%) |
| Mar 2002 | - | $3.69 M(+2.8%) |
| Dec 2001 | $3.58 M(-9.9%) | $3.58 M(-6.4%) |
| Sept 2001 | - | $3.83 M(+1.0%) |
| June 2001 | - | $3.79 M(+0.7%) |
| Mar 2001 | - | $3.77 M(-5.3%) |
| Dec 2000 | $3.98 M | $3.98 M(+8.0%) |
| Sept 2000 | - | $3.69 M(-7.7%) |
| June 2000 | - | $3.99 M(+4.4%) |
| Mar 2000 | - | $3.82 M |
FAQ
- What is Utah Medical Products annual accounts receivable?
- What is the all time high annual accounts receivable for Utah Medical Products?
- What is Utah Medical Products annual accounts receivable year-on-year change?
- What is Utah Medical Products quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Utah Medical Products?
- What is Utah Medical Products quarterly accounts receivable year-on-year change?
What is Utah Medical Products annual accounts receivable?
The current annual accounts receivable of UTMD is $3.49 M
What is the all time high annual accounts receivable for Utah Medical Products?
Utah Medical Products all-time high annual accounts receivable is $5.54 M
What is Utah Medical Products annual accounts receivable year-on-year change?
Over the past year, UTMD annual accounts receivable has changed by -$2.05 M (-37.02%)
What is Utah Medical Products quarterly accounts receivable?
The current quarterly accounts receivable of UTMD is $3.72 M
What is the all time high quarterly accounts receivable for Utah Medical Products?
Utah Medical Products all-time high quarterly accounts receivable is $6.07 M
What is Utah Medical Products quarterly accounts receivable year-on-year change?
Over the past year, UTMD quarterly accounts receivable has changed by +$233.00 K (+6.68%)